FDAFDA · Food and drugs·Recall number D-1470-2016
Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: Teva Canada Limited, Toronto, Canada, NDC 0093-4161-76
Published August 31, 2016 · Recall initiated: June 24, 2016
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent drug: Out of specification test result for assay during stability testing.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- AMOXICILLIN
- Manufacturer
- Teva North America
- Distributor
- Nationwide
- UPC
- 0300933107051
- Lot
- Lot # 35434158A, Exp 6/17
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.